Quantcast

Latest Pharmaceutical industry in India Stories

2014-05-06 08:36:41

--PDL's Revolutionary Antibody Technology Provided Basis for Eight Successful Drugs Currently on the Market-- INCLINE VILLAGE, Nev., May 6, 2014 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that two inventors of the company's patented breakthrough antibody technology have been named as a top-three finalist for the European Patent Office's highly prestigious 2014 European Inventor Award in the "Non-European Countries" category. The award, which is...

2014-05-01 20:24:02

DUBLIN, May 1, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/dfhjv9/global_orphan) have announced the addition of the "Global Orphan Drugs Market 2014-2018" [http://www.researchandmarkets.com/research/dfhjv9/global_orphan ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The analysts forecast the Global Orphan Drugs market to grow at a CAGR of 5.67 percent over the period 2013-2018....

2014-05-01 08:37:39

DUBLIN, May 1, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/sdjlqk/global_generic) has announced the addition of the "Global Generic Drugs Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 The analysts forecast the Global Generic Drugs market to grow at a CAGR of 11.02 percent over the period 2013-2018. The patent expiry of top-selling drugs is one of the major drivers contributing to the growth of this...

2014-04-29 23:22:06

Gallus BioPharmaceuticals, a premier pure-play biologics contract development and manufacturing organization and Omni Bio Pharmaceutical, a biopharmaceutical company focused on the commercialization of alternative uses of alpha-1 antitrypsin (AAT), jointly announced finalization of a multi-stage manufacturing services agreement. St. Louis, Missouri (PRWEB) April 29, 2014 Gallus BioPharmaceuticals, LLC(Gallus), a premier pure-play biologics contract development and manufacturing...

2014-04-23 23:04:16

New research study “Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics” worked out by CurrentPartnering is now available at MarketPublishers.com. London, UK (PRWEB) April 23, 2014 Evaluation agreements enable a partner to the deal to gain rights to a technology or compound, subject to a span of time to evaluate the scope, applicability and quality of the technology to its desired endpoint. Typically, the technology is in the initial stage and/or...

2014-04-16 08:31:53

- Bloss to serve on Astellas US Management Committee - NORTHBROOK, Ill., April 16, 2014 /PRNewswire/ -- Astellas US LLC, a subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced Jeffrey D. Bloss, M.D., has been promoted to the position of Senior Vice President, Medical Affairs Americas, Astellas Scientific and Medical Affairs (ASMA), effective April 1. Bloss will serve as a member of the Astellas US Management Committee. "Jeff has been a key partner and thought...

2014-04-10 12:28:29

LONDON, April 10, 2014 /PRNewswire/ -- Increasing government regulations and requirements, the pharmaceutical patent cliff, industry consolidation, counterfeits and contaminants and expansion into emerging markets are among the many challenges facing the healthcare industry. However, with these challenges come opportunities and not just for the healthcare manufacturer but also for the logistics provider. Ti's latest report, 2014 Global Healthcare Logistics...

2014-04-08 16:22:55

Exec to Support Life Science Research Clients in Booming Southwestern Market SALT LAKE CITY, April 8, 2014 /PRNewswire/ -- Numira, a leader in high resolution, 3D imaging services, visualization software, and cloud computing for the life science market, today announced the appointment of Kim Killian as Regional Sales Manager of the Southwestern region. "As we've seen remarkable growth opportunities in the western United States, we knew we needed to bring on new and exceptional...

2014-04-07 08:30:43

BOSTON, April 7, 2014 /PRNewswire/ -- Piramal Enterprises' Pharma Solutions Division, a global pharmaceutical contract development and manufacturing organization (CDMO), has received CMO Leadership Awards 2013 in two categories - Quality and Reliability, at a prestigious ceremony at DCAT in New York. Within the Reliability category, Piramal has been recognized as the most "Reliable" CMO among the 5 CMOs shortlisted for this award. (Logo:...

2014-04-04 12:27:58

DUBLIN, Apr. 04, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/8mt3ng/membrane ) has announced the addition of the "Membrane Technology Market- Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2019" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) Globally, the membrane technology market is witnessing significant growth due to increasing research and development and production in...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related